Evidence map›Paper›PMID 35141983›Full record

ArticleThe European journal of neuroscience2022

α7 nicotinic acetylcholine receptor modulation of accumbal dopamine release covaries with novelty seeking.

Amy C Leach, Elizabeth G Pitts, Cody A Siciliano, Mark J Ferris

Open access · greenAbstract read
In one paragraph

Article in The European journal of neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Amy C LeachDepartment of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.ORCID 0000-0003-3683-8633
Elizabeth G PittsDepartment of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Cody A SicilianoDepartment of Pharmacology, Vanderbilt Center for Addiction Research, Vanderbilt University, Nashville, Tennessee, USA.
Mark J FerrisDepartment of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.ORCID 0000-0002-0127-7955
Wake Forest University · USVanderbilt University · US

Funding

TROPANE EVALUATION AND GENERAL SCIENTIFIC SERVICES COREP50DA006634 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI PORRINO, LINDA J. · 1991 to 2019
$30.8M
Wake Forest Translational Alcohol Research Center (WF-TARC)P50AA026117 · NIAAA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Paul W. Czoty · 2018 to 2026
$16.2M
Circadian Rhythms and Cocaine Use DisorderR01DA052460 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI FERRIS, MARK J · 2021 to 2025
$2.2M
The Neurobiology of Drug AbuseT32DA041349 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI SARA RAULERSON JONES · 2017 to 2026
$1.8M
Defining the role of cortical circuit dynamics in learning and addictionR00DA045103 · NIDA · VANDERBILT UNIVERSITY · PI SICILIANO, CODY · 2020 to 2022
$764k
nAChR sensitivity and individual differences in drug abuse vulnerabilityR00DA031791 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI FERRIS, MARK J · 2015 to 2017
$743k
Differential Nicotinic Acetylcholine Receptor Modulation of Striatal Dopamine Release as a Mechanism Underlying Individual Differences in Drug Acquisition RatesF31DA053114 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI LEACH, AMY CLAIRE · 2022 to 2023
$94k
The impact of adolescent nicotine self-administration on neurochemistry, neurophysiology, and alcohol consumptionF32AA028162 · NIAAA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI PITTS, ELIZABETH G · 2019 to 2019
$61k
NIAAA NIH HHS F32 AA028162NIAAA NIH HHS P50 AA026117NIDA NIH HHS F31 DA053114NIDA NIH HHS P50 DA006634NIDA NIH HHS R00 DA031791NIDA NIH HHS R00 DA045103NIDA NIH HHS R01 DA052460NIDA NIH HHS T32 DA041349
6 · The paper itself

Abstract

Heightened novelty-seeking phenotypes are associated with a range of behavioural traits including susceptibility to drug use. These relationships are recapitulated in preclinical models, where rats that exhibit increased exploratory activity in novel environments (high responders-HR) acquire self-administration of psychostimulants more rapidly compared to rats that display low novelty exploration (low responders-LR). Dopamine release dynamics in the nucleus accumbens (NAc) covaries with response to novelty, and differences in dopaminergic signalling are thought to be a major underlying driver of the link between novelty seeking and drug use vulnerability. Accumbal dopamine release is controlled by local microcircuits including modulation through glutamatergic and nicotinic acetylcholine receptor (nAChR) systems, but whether these mechanisms contribute to disparate dopamine signalling across novelty phenotypes is unclear. Here, we used ex vivo voltammetry in the NAc of rats to determine if α7 nAChRs contribute to differential dopamine dynamics associated with individual differences in novelty exploration. We found that blockade of α7 nAChRs attenuates tonic dopamine release evoked by low-frequency stimulations across phenotypes but that phasic release is decreased in LRs while HRs are unaffected. These stimulation frequency- and phenotype-dependent effects result in a decreased dynamic range of release exclusively in LRs. Furthermore, we found that differential α7 modulation of dopamine release in LRs is dependent on AMPA but not NMDA receptors. These results help to form an understanding of the local NAc microcircuitry and provide a potential mechanism for covariance of dopamine dynamics and sensitivity to the reinforcing effects of drugs of abuse.

Indexed as

DopamineReceptors, Nicotinicalpha7 Nicotinic Acetylcholine ReceptorAnimalsExploratory BehaviorNucleus AccumbensRatsalpha7 Nicotinic Acetylcholine ReceptorChrna7 protein, ratDopamineReceptors, Nicotinicindividual differencesnicotineSUDvoltammetryvulnerability

Identifiers

PMID35141983
PMCPMC9586210
OpenAlexW4211004222

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.